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What do the results mean?
Estimating disease prevalence in the 50 
US states may sound a bit dull to some 
readers, but quantifying such burden 
of disease is a crucial step in planning 
appropriate services, especially if such 
data can be coupled with disease sever-
ity and health-care usage (Chren and 
Weinstock, 2004). The data thus pro-
vide the most basic of building blocks 
for a Needs Assessment of National and 
State dermatology services for young 
people (Schofield et al., 2009). Second, 
the variation in disease prevalence with 
factors such as geographical location, 
ethnic group, and educational status, if 
true, signals that the environment is criti-
cal for determining disease expression in 
eczema. Although genetic factors such as 
filaggrin gene mutations help to explain 
some variation in eczema (Rodríguez et 
al., 2009), it is likely that interaction with 
environmental factors plays a critical 
role given the associations shown in this 
study and the increasing prevalence of 
disease over the past 20 years (Williams 
et al., 2008). The study findings do not 
mean that a young, black, well-educat-
ed, English-speaking resident of a city on 
the East Coast of the United States will 
necessarily get eczema, because these 
associations relate to aggregated risks 
and because they refer to attributes that 
point to more specific exposures such as 
diet, hygiene, and health behaviors. The 
challenge now is to identify the environ-
mental factors that are amenable to pub-
lic health manipulation in the hope that 
this knowledge will bring us one step 
closer to eczema prevention (Mar and 
Marks, 2000).
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Urocanic Acid in the skin:  
A Mixed Blessing?
Neil K. Gibbs1 and Mary Norval2
Located in the stratum corneum, urocanic acid is a major epidermal chromophore 
for UVR. This simple molecule has attracted a great deal of research interest over the 
past half century, initially as a putative “natural sunscreen” and later as a mediator of 
photoimmunosuppression with a consequent role in photocarcinogenesis. for the 
first time, Barresi and colleagues provide robust evidence for the photoprotective 
role of endogenous urocanic acid and reopen the debate on the relative “benefi-
cial” and “detrimental” properties of this molecule.
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Urocanic acid (UCA) was originally iso-
lated from the urine of a dog by Jaffé in 
1874, but the presence of epidermal 
UCA was only confirmed in the 1950s. 
Trans-UCA is produced in the mam-
malian stratum corneum by the action 
of l-histidine ammonia lyase (histidase; 
Hal) on histidine. The major source of 
histidine in this skin compartment is fil-
aggrin (formerly called histidine-rich 
protein) and reduced production of 
filag grin results in lower levels of UCA. 
Urocanase, the enzyme that catabolizes 
UCA in the liver, is absent in the skin, 
which allows accumulation of UCA up 
to 0.5% of the dry weight of the epider-
mis. In humans, epidermal UCA levels 
range from 4 to 34 nM/cm2 and do not 
correlate with any parameter so far tested 
including age, sex, pigmentation, skin 
phototype, and minimal erythema dose 
(see, for example, de Fine Olivarius et 
al., 1997). UCA has been proposed as the 
major acid–base regulator in the epider-
mis, although recent results demonstrate 
that the filaggrin–histidase–UCA cascade 
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is not essential for the acidification of the 
surface of the stratum corneum (Fluhr et 
al., 2010).
It was also established more than 50 
years ago that UCA is a major epidermal 
chromophore for UVR, which convinced 
investigators that the molecule existed 
in the stratum corneum as a “natural 
sunscreen” (Tabachnick, 1957). As the 
photochemical properties and impor-
tance of DNA became understood, the 
fact that the UCA absorption spectrum 
partially overlapped the DNA absorption 
spectrum added credence to this idea 
and led the cosmetics industry to include 
UCA in their skin products. This remained 
the situation for the following quarter of a 
century, which saw significant advances 
in UCA photochemistry; it became clear 
that trans-UCA could be photoisomer-
ized to cis-UCA on UVR exposure and 
this conversion was considered a “safe” 
way to disperse photon energy. The pho-
toisomerization reaction was reversible 
and both UCA isomers had very simi-
lar absorption properties. Such findings 
enhanced UCA’s reputation as an ideal 
natural sunscreen.
This “understanding” of the role of 
epidermal UCA was shattered with 
the seminal finding that UCA was a 
chromo phore for, and cis-UCA a media-
tor of, the immunosuppressive effects of 
UVR in the skin (de Fabo and Noonan, 
1983). Subsequent work by other groups 
confirmed the original finding, which 
prompted de Fabo and Noonan to sub-
mit a citizens’ petition in 1991 requesting 
the US Food and Drug Administration to 
find that “urocanic acid is a deleterious 
substance and may render any cosmetic 
product containing it injurious.” A review 
by the US Cosmetic Ingredient Review 
Expert Panel and the gradual removal of 
UCA from cosmetic products followed. 
From 1983 to date, research on UCA, with 
a few exceptions, has been dedicated to 
understanding its role in photoimmuno-
suppression and how this may increase 
photocarcinogenic risk. As a conse-
quence, the putative photoprotective role 
of UCA has not been considered a topic 
of much relevance or interest until now.
Early photoprotection experiments 
in guinea pigs, and more recently in 
humans, have demonstrated that photo-
protection offered by topical application 
of UCA is limited and approximately 
equivalent to a sunscreen with a sun pro-
tection factor (SPF) of 1.5. However, in 
these types of studies, exogenous UCA 
was administered above the UCA already 
existing in the stratum corneum, so the 
efficacy of UCA as an endogenous pho-
toprotectant per se was not assessed. 
Barresi and colleagues (2011, this issue) 
elegantly address this question using mice 
that are histidase-deficient because of a 
mutation in the Hal gene. These histidin-
emic animals have less than 10-fold the 
concentration of UCA in their stratum 
corneum than wild-type mice. Although 
a strain of histidase-deficient mice was 
available in the past (they were men-
tioned in de Fabo and Noonan, 1983), 
these animals were sickly and did not 
breed well. Barresi and colleagues’ study 
used animals resulting from a backcross 
between these original “Peruvian” mice 
and C57BL/6 mice, which has provided a 
healthier histidinemic strain. The authors 
demonstrate that after broadband UVB 
irradiation of 250 mJ cm−2 (which is likely 
to represent an erythemal dose), the lev-
els of DNA damage (thymine dimers; 
T^T) and markers of apoptosis (caspase-3 
and TUNEL) were about 40% higher 
in the epidermis of the histidinemic 
mice than in wild-type animals. The 
photosensitivity of the histidinemic mice 
to T^T induction could be abrogated by 
the topical application of a high concen-
tration of UCA.
Thus, for the first time, a photopro-
tective role for endogenous UCA has 
been demonstrated in mammalian skin. 
Quantitatively, the protection is similar 
to that afforded by topical UCA applied 
exogenously in the mouse and human 
studies conducted—an SPF of about 
1.5—which at first glance may seem 
small. However, unlike the vagaries of 
sunscreen application, endogenous UCA 
is a constitutive photoprotectant that 
should reduce some major deleterious 
UVR-induced effects by 33%.
The action spectrum for UVR-induced 
erythema in mammalian skin closely 
resembles that for T^T induction and 
erythemal responses are exaggerated if 
repair of these lesions is deficient, such 
as in certain xeroderma pigment osum 
complementation groups. It would there-
fore be expected that the protection 
offered by endo genous UCA against 
T^T, as demonstrated by Barresi and 
colleagues (2011), would translate to pro-
tection against erythema. Interestingly, 
the authors did not note any gross 
differences in skin pathology between the 
histidinemic and wild-type mice 24 hours 
after irradiation. One study examining 
the relationship between cutaneous UCA 
levels and erythemal photo sensitivity 
in humans found that, despite a 10-fold 
variation in UCA concentration, there 
was no correlation between these two 
parameters (de Fine Olivarius et al., 
1997). This is surprising because a strong 
inverse relationship would be expected 
between the concentration of UCA and 
UVR transmission if UCA was acting 
purely as a chemical sunscreen in the 
stratum corneum, and it suggests that 
UCA is acting in a more complex manner. 
Indeed, it has been variously reported that 
UCA can also photosensitize DNA dam-
age such as 6-4 photoproducts in vivo 
or cyclobutane adducts in vitro. Recent 
evidence suggests that treatment of cells 
with cis-UCA can produce oxidative 
DNA damage (8-oxo-deoxyguanosine) 
via the induction of intracellular reactive 
oxygen species (ROS; Sreevidya et al., 
2010). In keratino cyte cultures cis-UCA 
induced genes associated with apopto-
sis, cell growth arrest, and oxidative stress 
(Kaneko et al., 2008). The comparative 
contributions of these opposing mecha-
nisms to the erythemal response merit 
further investigation.
The implications of the findings of 
Barresi and coworkers (2011) for photo-
immuno suppression are intriguing. 
Experiments in mice reveal that 
removing or enhancing the repair of 
UVR-induced T^T, using photolyase or 
T4 endonuclease, reduces photoim-
munosuppression, thus suggesting a 
protective role for endogenous UCA in 
this pathway. In contrast, cis-UCA is an 
|
 Beneficial photo 
protection by 
exogenous urocanic 
acid contrasts with 
its detrimental 
photoimmuno-
suppressive effects.
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immunosuppressant. A report that intra-
cellular ROS may be induced by cis-UCA 
(Sreevidya et al., 2010) may explain what 
initially seemed a strange finding that 
an antioxidant (N-acetylcysteine) could 
reduce the immunosuppressive effects 
of topically applied cis-UCA (Hemelaar 
and Beijersbergen van Henegouwen, 
1996). UCA therefore appears to be 
protecting against T^T-mediated immu-
nosuppression at the same time that 
it is producing cis-UCA, which is an 
immunosuppressant, and also possibly 
inducing oxidative DNA damage, whose 
immunosuppressive role is unclear. It 
is probably no surprise that the action 
spectrum for the UV-induced systemic 
suppression of contact hypersensitivity in 
mice (de Fabo and Noonan, 1983) cor-
relates with neither the action spectrum 
for cis-UCA production in mouse skin 
(Gibbs et al., 1993) nor the action spec-
trum for T^T production. Thus, it is likely 
that a complex contribution of both 
chromophores leads to immunosup-
pression via a myriad of pathways. These 
multifarious effects of UCA on photo-
immunosuppression are particularly 
important when its role in photocarcino-
genesis is considered.
The derived action spectrum for 
nonmelanoma skin cancer in humans 
(SCUP-h) closely mirrors that for 
epidermal T^T formation. Barresi and 
coworkers (2011) clearly show that UCA 
protects against the production of T^T, so 
the presence of UCA would be expected 
to protect against photocarcinogenesis. 
However, several studies have shown 
no difference in cutaneous UCA content 
between those subjects with a past 
history of nonmelanoma skin cancer or 
cutaneous malignant melanoma and 
healthy controls.
Although the experiment comparing 
photocarcinogenesis in wild-type 
and histidinemic mice has not yet 
been reported, existing evidence 
demonstrates that increasing the trans-
UCA content of mouse skin enhances 
photocarcinogenesis (Reeve et al., 1989). 
This suggests that, although increased 
UCA may reduce T^T levels, the con-
sequent reduction in tumor initiation 
and T^T-mediated photoimmuno-
suppression is not sufficient to counter 
the simultaneous increase in the level 
of cis-UCA, which is known to enhance 
photocarcinogenesis (Beissert et al., 
2001). The contributions of cis-UCA-
induced intracellular ROS formation 
(Sreevidya et al., 2010) and the recently 
reported ability of cis-UCA to induce 
the apoptosis of tumor cells through 
intra cellular acidification (Laihia et al., 
2010) should be taken into account 
when attempting to unravel the very 
confusing overall contribution of UCA 
to the photo carcinogenic process.
Summary
The evidence presented by Barresi and 
colleagues (2011) suggests that trans-
UCA acts as a natural sunscreen, giving 
lifelong, low-level protection against 
UVR-induced DNA damage and exces-
sive keratinocyte apoptosis. However, 
cis-UCA, in addition to its well-reported 
immunosuppressive properties, may also 
initiate intracellular ROS production, 
oxidative DNA damage, and cell 
signaling that may negate any photo-
protective effect (Figure 1). There is an 
obvious need to examine the relative 
susceptibility of wild-type and histidine-
mic mice to photo immunosuppression 
and photo tumorigenesis and also to 
assess the relevant photoresponses in 
histidinemic humans.
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Lymphangiogenesis Linked  
to VeGf-C from Tumor-Associated 
Macrophages: Accomplices  
to Metastasis by Cutaneous 
squamous Cell Carcinoma?
Martin S. Kluger1 and Oscar R. Colegio2
During wound healing, dermal macrophages secrete lymphangiogenic 
vascular endothelial growth factor (VeGf)-C, and lymphatic vessels transport 
cytokines and cells to draining lymph nodes. In this issue, Moussai et al. 
show that macrophages in peritumoral nonlesional skin near squamous cell 
carcinoma secrete prolymphangiogenic VeGf-C. Their study suggests how 
tumor-associated macrophages and neolymphatic vessels may coordinate 
metastasis starting early in cutaneous squamous cell carcinoma.
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roles for macrophage and  
lymphatic endothelial cells  
near squamous cell carcinoma
The primary functions of macrophages 
were first characterized in settings of 
classical inflammation in which they 
exert antimicrobial activity, serve as 
antigen-presenting cells required for 
the adaptive immune response, and 
promote healing by tissue remodel-
ing at sites of injury. In contrast, 
tumor-associated macro phages (TAMs) 
are less inflammatory and contribute to 
tissue remodeling by promoting the pro-
liferation and migration of endothelial 
cells (ECs) that lead to growth of new 
lymphatic vessels (lymphangio genesis). 
The presence of TAMs generally 
correlates with a poor prognosis in most 
human cancers. Importantly, whereas 
lymph angiogenesis observed in many 
aggressive cancers correlates with 
meta stasis to regional lymph nodes 
(e.g., in cutaneous melanoma and in 
head/neck and oral squamous cell 
carcinoma (SCC)), the presence and 
character ization of prolymphangiogen-
ic TAMs in cutaneous SCC has not been 
previously described.
In this issue, Moussai et al. describe 
CD68+/CD163+ TAMs in peritumor-
al nonlesional skin (PTNL) of stage I 
cutaneous SCC as a source of vascu-
lar endothelial growth factor (VEGF)-C 
that correlates with an increase in lym-
phatic vessel density (LVD). These data 
showing lymphangio genic VEGF-C 
produced by a defined subpopulation 
of TAMs raise a number of interesting 
questions about how macrophage-driv-
en lymphangiogenesis may promote 
metastasis in SCC. Furthermore, these 
findings invite investigation of mole-
cules expressed by lymphatic endothe-
lial cells (LECs), or at recruitment of 
prolymphangiogenic TAMs, as poten-
tial therapeutic targets for preventing 
life-threatening metastases to regional 
draining lymph nodes.
trophic macrophages are recruited  
by wounds and tumors
Macrophages are bone marrow–derived 
cells that initially circulate as mono-
cytes and subsequently differ entiate 
into tissue-resident macro phages. 
Resident macrophages support tissues 
by phagocytosing apoptotic cells, and 
they become trophic when activated, 
secreting growth, angiogenic, and 
lymphangiogenic factors needed for 
tissue remodeling. Wounding of tis-
sues triggers an acute inflammatory 
response, characterized by the pro-
duction of numerous cyto kines and 
chemokines, which recruit and differ-
entiate additional circulating mono-
cytes into macrophages. Wound-
associated macrophages have been 
proposed to coordinate new tissue 
formation and remodeling. More 
specifically, macrophages have been 
found to regulate vasculogenesis in 
wound healing. Whereas the specific 
